https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04724-0
Advancing personalized medicine in brain cancer relies on innovative strategies, with mRNA vaccines emerging as a promising avenue. While the initial use of mRNA vaccines was in oncology, their stunning success in COVID-19 resulted in widespread attention, bo…
Create an account or login to join the discussion